“showed a trend”

Using univariate analysis, the follow-up SUV max showed a trend for a worse survival with higher SUV max (HR 1.196, 95% CI 0.926–1.543, P =0.170).

After irAEs were resolved, ICI resumption showed a trend towards improved PFS (12.1 vs. 7.9 months, p=0.17) and OS (27.5 vs. 18.0 months, p=0.73) ( Fig. 3 ). 7.

They also showed that patients who relapsed early after the repopulation of peripheral blood B cells showed a trend ( p = 0.170) for a higher percentage of CD19 + CD27 + memory B cells than those who relapsed later.

Ipatasertib 400 mg showed a trend to increased radiological PFS (median 8.18 vs. 6.37 months; HR = 0.75; p = 0.17) and increased OS (median 18.92 months vs. 15.64 months; HR = 0.72; p = 0.22), compared to placebo.

Among the responders, the AC heterozygous patients showed a trend towards a reverse association with a response to the therapy with TNF-α inhibitors (OR = 0.52, 95% CI 0.21–1.32, p = 0.17) whereas the CC homozygous cases showed a 12-fold reduced chance of responding to therapy compared with AA homozygotes (OR = 0.082, 95% CI 0.009–0.78, p = 0.029) ( Figure 1 ).

From the downregulated genes of the EMT-core gene list, low FXYD3 expression showed a trend to poor overall survival of SCC patients (p = 0.17) and low expression of LAD1 (p = 0.00074), SLC7A5 (p = 0.0093) and SLPI (p = 0.043) significantly correlated with worse pCR of breast cancer patients.

TI activity showed a trend toward increasing in trials with ABF (p = 0.17) but this change was particularly clear only for subjects #4 and #7.

A retrospective study ( n = 87) has compared both techniques for <10 mm lesions and ESD showed a trend to a better pathologically complete resection rate (95% vs. 83%, p = 0.17) and a trend to a higher adverse event rate (perforation 2.6% vs. 0%, delayed bleeding 5.1% vs. 4.2%), but with no statistically significant differences [ 20 ].

Combining ecozones into temperate (Atlantic Maritime and Mixedwood Plains), boreal (Boreal Plains and Boreal Shield) and subarctic (Hudson Plains, Taiga Plains and Taiga Shield) regions showed a trend of daily NEE from temperate < subarctic < boreal (p = 0.17).

Among the other available variables, V37 Gy (cc) was of borderline significance while MLD > 5.5 Gy, hypertension and smoking showed a trend ( p -value = 0.17 and 0.20 respectively) with ORs around 2.

TB patients showed a trend towards higher baseline viral loads, with 54% having > 1,000,000 copies/ml compared to 44% in non-TB patients ( P = 0.17).

Participants with Mini MoCA scores <11, indicating cognitive risk, showed a trend ( p = .17; see Table 2 ) to have been a caregiver (46%), compared to those who scored >11 (32%).

All of those with a BMI ≥25.0 versus healthy BMI showed a trend toward requiring a larger total gonadotrophin dose (SMD=0.21, 95% CIs −0.09 to 0.51, p=0.17) ( online supplemental figure 2C ).

Although no significant difference was observed, the PC group showed a trend towards a higher radical resection rate (RR, 1.10; 95 % CI, 0.96 to 1.27; P = 0.17, Fig. 3a ).

Model 3, incorporating liver masks as a second channel, showed a trend toward enhanced cyst detection, with an average PDice of 82% ± 11% vs 79% ± 11% ( P = .17) and VTPR of 75% ± 15%, outperforming Model 1.

In models adjusted for key confounders of CAR T-cell target and cytokine release syndrome and/or immune effector cell–associated neurotoxicity syndrome grade ≥2, CMV showed a trend toward increased OM, particularly in patients with CMV reactivation ≥150 IU/mL (adjusted hazard ratio, 2.42; 95% CI, 0.69-8.47; P = .17; Figure 2 ), but this did not reach statistical significance.

In contrast, CADABRA (red boxplots) showed a trend to overscore very low fighting pairs (Fig. 1c , Kruskal–Wallis ANNOVA with Dunn’s test, 0–20, p = 0.17, n = 14) and significantly underscored moderate to very high fighting pairs (Fig. 1c , Kruskal–Wallis ANNOVA with Dunn’s test; 21–100: p = 0.040; 101–300: p < 0.0001; >300, p < 0.0001, n = 15 per group).

While not reaching statistical significance, we did observe that in the ROR-low group of ERpHER2nLNn adjuvant endocrine-treated group of patients >50 years at diagnosis, patients with LumA NC – Normal NC_2nd tumors showed a trend toward better overall survival (log-rank p = 0.17, Fig. 2e ).

Among the six types of medications taken by the men with DM (sulfonylureas, biguanides, dipeptidyl peptidase-4 inhibitors, α-glucosidase inhibitors, and insulin), sulfonylurea treatment was significantly associated with longer PFS (HR, 95% CI: 0.36, 0.12–0.90; P = 0.028) and showed a trend, albeit not significant, toward association with longer OS (HR, 95% CI: 0.52, 0.18–1.30; P = 0.17).

We found that both LDP and LPD showed a trend of less overall morbidity without statistical significance in contrast to ODP and OPD (DP: 9.3% vs. 16.3%, p = 0.17; PD: 21.8% vs. 31.7%, p = 0.11).

This was validated by a western blot analysis that showed a trend for reduced abundance of MGLL in HWL than in LWL AT PP ( P < 0.17, Fig 6B ).

Meta-analysis showed a trend toward reducing the level of LDL (MD = -2.34; 95% CI:-5.67 to 0.99; I 2 = 13%; p = 0.17) by fixed effects model (Fig. 2 c) and increasing the level of HDL (MD = 2.33; 95% CI: -0.27 ~ 4.92; I 2 = 82%; p = 0.08) (Fig. 2 d), but the beneficial effects of Mediterranean diet compared with control diets were not statistically significant.

In response to the stronger 4 ms HFU 30 + stimulation at 30 min, target spines showed a trend toward growth ( Fig. 4 A and B and SI Appendix , Table S1 ; 136 ± 6% P = 0.17).

We did not find significant tumor PAI at these loci, though CDKN2A and IKZF1 SNPs showed a trend towards preferential selection of the risk allele (p = 0.17 and p = 0.23, respectively).

There was no significant difference in the amount of chronic stress between the two groups of subjects in the preceding month, but patients with fibromyalgia showed a trend towards a greater exposure to chronic stress (20.00 versus 14.38, p = .17, see table 1 ).